- Home
- QVCGA vs KALA Comparison
QVCGA vs KALA Comparison
Compare QVCGA & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- KALA
- Stock Information
- Founded
- QVCGA 1991
- KALA 2009
- Country
- QVCGA United States
- KALA United States
- Employees
- QVCGA N/A
- KALA N/A
- Industry
- QVCGA
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGA
- KALA Health Care
- Exchange
- QVCGA NYSE
- KALA Nasdaq
- Market Cap
- QVCGA 26.1M
- KALA 26.2M
- IPO Year
- QVCGA N/A
- KALA 2017
- Fundamental
- Price
- QVCGA $2.64
- KALA $6.08
- Analyst Decision
- QVCGA
- KALA Strong Buy
- Analyst Count
- QVCGA 0
- KALA 3
- Target Price
- QVCGA N/A
- KALA $14.00
- AVG Volume (30 Days)
- QVCGA 104.1K
- KALA 133.6K
- Earning Date
- QVCGA 08-07-2025
- KALA 08-05-2025
- Dividend Yield
- QVCGA N/A
- KALA N/A
- EPS Growth
- QVCGA N/A
- KALA N/A
- EPS
- QVCGA N/A
- KALA N/A
- Revenue
- QVCGA $9,800,000,000.00
- KALA N/A
- Revenue This Year
- QVCGA $2.89
- KALA N/A
- Revenue Next Year
- QVCGA $0.45
- KALA N/A
- P/E Ratio
- QVCGA N/A
- KALA N/A
- Revenue Growth
- QVCGA N/A
- KALA N/A
- 52 Week Low
- QVCGA $2.27
- KALA $2.92
- 52 Week High
- QVCGA $39.74
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- KALA 58.29
- Support Level
- QVCGA N/A
- KALA $5.39
- Resistance Level
- QVCGA N/A
- KALA $7.00
- Average True Range (ATR)
- QVCGA 0.00
- KALA 0.71
- MACD
- QVCGA 0.00
- KALA 0.04
- Stochastic Oscillator
- QVCGA 0.00
- KALA 51.89
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.